Orphanet: Recherche simple
x

Rechercher un essai clinique

* (*) Champ obligatoire

93 Résultat(s)

Trier par

Essai en cours de recrutement = Essai en cours de recrutement; Essai en cours = Essai en cours; Financé par un membre IRDiRC = ; Membre d'un ERN =

Essai(s) clinique(s) national(aux)

ALLEMAGNE

Baden-Württemberg
FREIBURG

Essai en coursFOR-DMD: Double-blind randomized phase III trial to find optimum steroid regimen for Duchenne Muscular Dystrophy - DE
Zentrum für Kinder- und Jugendmedizin Freiburg
Klinik für Neuropädiatrie und Muskelerkrankungen

ALLEMAGNE

Bayern
MÜNCHEN

ALLEMAGNE

Bayern
MÜNCHEN

CANADA

Ontario
LONDON

ETATS-UNIS

Florida
GAINESVILLE

ETATS-UNIS

New York
ROCHESTER

FRANCE

ILE-DE-FRANCE
PARIS

IRLANDE

County Dublin
DUBLIN

Essai en cours de recrutementEssai en coursPhase III Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy (PolarisDMD)-IE
Children's Health Ireland @ Temple Street
Department of Neurology

ITALIE

CAMPANIA
NAPOLI

Essai en cours(FOR-DMD): Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
AOU Università degli Studi della Campania "Luigi Vanvitelli" - Centro storico
Servizio di Cardiomiologia e Genetica Medica

ITALIE

LAZIO
ROMA

Essai en cours de recrutementEssai en coursOpen Label, Long-term Safety, Tolerability, and Efficacy Study of GIVINOSTAT in All DMD Patients Who Have Been Previously Treated in One of the GIVINOSTAT Studies - IT
IRCCS Ospedale Pediatrico Bambino Gesù - SEDE SAN PAOLO
Unità di Malattie Neuromuscolari e Neurodegenerative - Laboratorio di Medicina Molecolare

ROYAUME-UNI

Cambridgeshire
CAMBRIDGE

ROYAUME-UNI

Greater London
LONDON

ROYAUME-UNI

Tyne & Wear
NEWCASTLE UPON TYNE

Essai en cours de recrutementEssai en coursFinancé par un membre IRDiRCA Phase III Efficacy and Safety Study of Ataluren (PTC124) in Patients with Nonsense Mutation Dystrophinopathy - UK
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

ROYAUME-UNI

Tyne & Wear
NEWCASTLE UPON TYNE

Essai en coursAn open-label extension study of the long-term safety, tolerability and efficacy of GSK2402968 in subjects with Duchenne Muscular Dystrophy (phase III) - UK
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

ROYAUME-UNI

Tyne & Wear
NEWCASTLE UPON TYNE

Essai en coursAn Open-Label Study for Previously Treated Ataluren (PTC124®) Patients with Nonsense Mutation Dystrophinopathy (phase III) - UK
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

SUISSE

Suisse Alémanique
BASEL

Essai(s) clinique(s) multinational(aux)

ETATS-UNIS

Washington
ADDRESS: NOT PROVIDED - US

ROYAUME-UNI

Tyne & Wear
NEWCASTLE UPON TYNE

Financé par un membre IRDiRCSCOPE-DMD: Consortium for Products across Europe in Duchenne Muscular Dystrophy
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine